Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23969788 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Primary Peritoneal Carcinoma;   Stage III Ovarian Cancer;   Stage IV Ovarian Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Gemcitabine Hydrochloride;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Drug: Topotecan Hydrochloride;   Procedure: Therapeutic Conventional Surgery

Study has passed its completion date and status has not been verified in more than two years.